A Phase II, Randomized, Double-blind, Placebo-controlled Study to Examine the Effects of DAS181 in Immunocompromised Subjects With Lower Respiratory Tract Parainfluenza Infection on Supplemental Oxygen
Clinical trial NCT01644877 · COMPLETED
Trial details
- NCT number
- NCT01644877
- Sponsor
- Ansun Biopharma, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2016-12-15
- Enrollment
- 111
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.